Nifty 17938.4 (-0.96%)
Sensex 60098.82 (-1.08%)
Nifty Bank 38041.35 (-0.44%)
Nifty IT 37281.7 (-2.13%)
Nifty Financial Services 18269.95 (-1.08%)
Adani Ports 744.20 (-2.46%)
Asian Paints 3280.40 (-2.77%)
Axis Bank 729.60 (0.61%)
B P C L 394.35 (-0.94%)
Bajaj Auto 3436.80 (1.05%)
Bajaj Finance 7571.80 (-2.22%)
Bajaj Finserv 18077.30 (-0.42%)
Bharti Airtel 703.70 (-1.49%)
Britannia Inds. 3575.65 (-1.28%)
Cipla 895.65 (-0.72%)
Coal India 163.90 (1.93%)
Divis Lab. 4481.50 (-1.01%)
Dr Reddys Labs 4684.95 (-0.18%)
Eicher Motors 2718.70 (-0.64%)
Grasim Inds 1806.50 (-2.47%)
H D F C 2620.25 (-1.59%)
HCL Technologies 1199.20 (-1.68%)
HDFC Bank 1518.45 (-0.71%)
HDFC Life Insur. 656.05 (-1.95%)
Hero Motocorp 2699.80 (0.26%)
Hind. Unilever 2309.90 (-2.52%)
Hindalco Inds. 504.80 (1.77%)
I O C L 125.10 (0.93%)
ICICI Bank 808.60 (-1.76%)
IndusInd Bank 893.25 (-0.71%)
Infosys 1867.05 (-2.80%)
ITC 220.35 (-0.18%)
JSW Steel 674.65 (-0.82%)
Kotak Mah. Bank 1905.65 (-1.88%)
Larsen & Toubro 2020.90 (-0.06%)
M & M 894.40 (0.25%)
Maruti Suzuki 8015.70 (1.27%)
Nestle India 18937.00 (-2.28%)
NTPC 134.80 (-0.15%)
O N G C 170.25 (3.91%)
Power Grid Corpn 204.65 (-0.24%)
Reliance Industr 2521.60 (-0.01%)
SBI Life Insuran 1248.10 (-1.41%)
Shree Cement 26402.25 (-2.77%)
St Bk of India 515.80 (1.78%)
Sun Pharma.Inds. 838.50 (-0.97%)
Tata Consumer 717.65 (-1.89%)
Tata Motors 520.85 (1.97%)
Tata Steel 1209.60 (1.23%)
TCS 3914.65 (-1.90%)
Tech Mahindra 1670.10 (0.56%)
Titan Company 2588.90 (-0.45%)
UltraTech Cem. 7434.40 (-1.61%)
UPL 813.25 (1.77%)
Wipro 621.15 (-1.92%)
GUFICBIO

Gufic BioSciences Ltd.

₹257.9

Investment Ratings

  • Master Rating:
  • Gufic Biosciences has an operating revenue of Rs. 721.24 Cr. on a trailing 12-month basis. An annual revenue growth of 28% is outstanding, Pre-tax margin of 12% is healthy, ROE of 25% is exceptional. The company has a reasonable debt to equity of 20%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 32% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 7% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 91 which is a GREAT score indicating consistency in earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Recommendation HoldBuy Sell

Result Highlights

Gufic BioSciences Ltd Synopsis

NSE-Medical-Generic Drugs

Gufic Biosciences Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 487.70 Cr. and Equity Capital is Rs. 9.69 Cr. for the Year ended 31/03/2021. Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519.
  • Market Cap

    INR 2,500.21 Cr

  • Sales

    INR 721.24 Cr

  • Shares in Float

    2.42 Cr

  • No of Funds

    10 K

  • Yield

    0.04%

  • Book Value

    14.42

  • U/D Vol Ratio

    1.9

  • LTDebt/Equity

    20%

  • Alpha

    0.25

  • Beta

    1.1

Gufic BioSciences Ltd Ownership
Gufic BioSciences Ltd Management

Gufic BioSciences Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Gufic BioSciences Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 173.44129.3275.3553.5237.33
Fixed Assets Annual Cr 113.37113.1934.0724.3722.00
Total Non Current Assets Annual Cr 131.48134.2147.0339.0435.22
Total Current Assets Annual Cr 260.58273.31232.51197.04143.25
Total Assets Annual Cr 392.06407.52279.54236.07178.46
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 17.8913.349.686.924.83
ROE Annual % 25.5017.5429.1129.9324.16
ROCE Annual % 31.2326.2548.8353.4741.17
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 17.9715.2814.2913.659.93

Gufic BioSciences Ltd Technicals

EMA & SMA

CURRENT PRICE

257.9 (3.14)

    • Bullish Moving Averages 15
    • Bearish Moving Averages 1

EMA

  • 20 Day

    243.31

  • 50 Day

    224.96

  • 100 Day

    209.77

  • 200 Day

    189

Gufic BioSciences Ltd Resistance and support

255.3 PIVOT

  • First Resistance

    262.7

  • Second Resistance

    275.36

  • Third Resistance

    282.75

  • First Support

    242.65

  • Second Support

    235.25

  • Third Support

    222.6

  • RSI

    62.99

  • MFI

    78.98

  • MACD

    12.07

  • MACD signal line

    11.73

Gufic BioSciences Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 335,756 11,956,271 35.61%
Week 490,512 19,983,443 40.74%
1 Month 712,384 26,913,876 37.78%
6 Month 510,296 22,611,205 44.31%

Gufic BioSciences Ltd Price change analysis

49.95

Over 1 month

Low High
195.15 270.1

67.3

Over 3 month

Low High
170.2 270.1

78.85

Over 6 months

Low High
170.2 270.1

135.6

Over Year

Low High
99 270.1

Corporate Action

Date Purpose Remarks
2021-11-03 Quarterly Results
2021-08-11 Quarterly Results
2021-06-04 Audited Results & Final Dividend
2021-02-08 Quarterly Results
2020-11-12 Quarterly Results

MF Shareholding

Similar Stocks

News

GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Investor Comp

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor compl Read More

GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Certificate un

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, please find enclosed herewith the letter received Read More

GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window

This is to inform you that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and th Read More

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulat

In terms of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Read More

GUFIC BIOSCIENCES LTD. - 509079 - Shareholder Meeting / Post

Pursuant to Regulation 30 of the Securities Exchange Board Of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we Read More

FAQs

Stock Directory-

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All 0-9